283 related articles for article (PubMed ID: 8191164)
1. [Diagnosis of von Willebrand's disease subtypes by the analysis of multimeric composition of plasma von Willebrand factor].
Quiroga T; Pérez M; Pereira J; Mezzano D
Rev Med Chil; 1993 Sep; 121(9):987-93. PubMed ID: 8191164
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
3. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
McCarroll DR; Ruggeri ZM; Montgomery RR
J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
[TBL] [Abstract][Full Text] [Related]
4. [Willebrand's disease and multimeric analysis of the Willebrand factor].
Hauert J; Tran-Thang C; Bachmann F
Schweiz Med Wochenschr; 1985 Dec; 115(49):1773-5. PubMed ID: 3879003
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic strategies for detection of the von Willebrand syndrome].
Eller T; Mayer J; Bomhard M; Keller F
Beitr Infusionsther; 1992; 30():268-71. PubMed ID: 1284714
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
8. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
Favaloro EJ
Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
[TBL] [Abstract][Full Text] [Related]
9. Improved characterization of plasma von Willebrand factor heterogeneity when using 2.5% agarose gel electrophoresis.
Mazurier C; Samor B; Goudemand M
Thromb Haemost; 1986 Feb; 55(1):61-4. PubMed ID: 3486491
[TBL] [Abstract][Full Text] [Related]
10. Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand disease.
Takahashi Y; Kalafatis M; Girma JP; Meyer D
Thromb Haemost; 1988 Dec; 60(3):498-505. PubMed ID: 3266380
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.
Rodeghiero F; Castaman G; Tosetto A
Thromb Haemost; 1990 Nov; 64(3):349-52. PubMed ID: 2096485
[TBL] [Abstract][Full Text] [Related]
12. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
[TBL] [Abstract][Full Text] [Related]
13. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
15. The multimeric pattern of von Willebrand's factor (vWF) can be demonstrated also in the severe form of the disease.
Pezzetti L; Redaelli R; Caimi TM; Cattaneo D; Baudo F; De Cataldo F
Int J Hematol; 1992 Feb; 55(1):89-91. PubMed ID: 1581588
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
17. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
18. Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers.
Brooks M; Raymond S; Catalfamo J
J Am Vet Med Assoc; 1996 Sep; 209(5):930-3. PubMed ID: 8790543
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
Favaloro EJ
Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems.
Favaloro EJ; Henniker A; Facey D; Hertzberg M
Thromb Haemost; 2000 Oct; 84(4):541-7. PubMed ID: 11057847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
